Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

被引：15

作者：

Korenblik, R. ^{[1
,2
]}

Olij, B. ^{[1
,2
]}

Aldrighetti, L. A. ^{[10
]}

Abu Hilal, M. ^{[11
]}

Ahle, M. ^{[12
]}

Arslan, B. ^{[8
]}

van Baardewijk, L. J. ^{[13
]}

Baclija, I ^{[14
]}

Bent, C. ^{[15
,16
]}

Bertrand, C. L. ^{[17
]}

Bjornsson, B. ^{[18
]}

de Boer, M. T. ^{[19
]}

de Boer, S. W. ^{[3
]}

Bokkers, R. P. H. ^{[20
]}

Rinkes, I. H. M. Borel ^{[21
]}

Breitenstein, S. ^{[6
]}

Bruijnen, R. C. G. ^{[22
]}

Bruners, P. ^{[5
]}

Camacho, J. C. ^{[24
]}

Cappelli, A. ^{[25
]}

Carling, U. ^{[26
]}

Chan, B. K. Y. ^{[27
]}

Chang, D. H. ^{[28
]}

Choi, J. ^{[29
]}

Codina Font, J. ^{[30
]}

Crawford, M. ^{[31
]}

Croagh, D. ^{[32
]}

Cugat, E. ^{[33
]}

Davis, R. ^{[34
]}

De Boo, D. W. ^{[35
]}

De Cobelli, F. ^{[36
]}

De Wispelaere, J. F. ^{[37
]}

van Delden, O. M. ^{[38
]}

Delle, M. ^{[39
]}

Detry, O. ^{[40
]}

Dili, A. ^{[17
]}

Erdmann, J., I ^{[41
]}

Fisher, O. ^{[31
]}

Fondevila, C. ^{[42
]}

Fretland, A. ^{[43
]}

Garcia Borobia, F. ^{[44
]}

Gelabert, A. ^{[45
,46
]}

Gerard, L. ^{[47
]}

Giuliante, F. ^{[48
]}

Gobardhan, P. D. ^{[49
]}

Gomez, F. ^{[50
]}

Grunberger, T. ^{[51
]}

Grunhagen, D. J. ^{[52
]}

Guitart, J. ^{[46
]}

Hagendoorn, J. ^{[21
]}

机构：

[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht Univ Singel 40, NL-6229 ET Maastricht, Netherlands

[2] Maastricht Univ Med Ctr, Dept Surg, Maastricht, Netherlands

[3] Maastricht Univ Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands

[4] Univ Hosp Aachen, Dept Gen Visceral & Transplant Surg, Aachen, Germany

[5] Univ Hosp Aachen, Dept Radiol, Aachen, Germany

[6] Cantonal Hosp Winterthur, Dept Gen & Visceral Surg, Winterthur, Switzerland

[7] Cantonal Hosp Winterthur, Dept Radiol, Winterthur, Switzerland

[8] Rush Univ Med Ctr, Dept Radiol, Chicago, IL USA

[9] Rush Univ Med Ctr Chicago, Dept Surg, Chicago, IL USA

[10] Osped San Raffaele, Dept Surg, Milan, Italy

[11] Fdn Poliambulanza, Dept Surg, Brescia, Italy

[12] Univ Hosp, Dept Radiol, Linkoping, Sweden

[13] Maxima Med Ctr, Dept Radiol, Eindhoven, Netherlands

[14] Clin Favoriten, Dept Radiol, Vienna, Austria

[15] Royal Bournemouth & Christchurch Hosp, Dept Radiol, Bournemouth, Dorset, England

[16] Royal Bournemouth & Christchurch Hosp, Dept Radiol, christuchurch, England

[17] CHU UCLouvain Namur, Dept Surg, Namur, Belgium

[18] Linkoping Univ Hosp, Dept Surg Biomed & Clin Sci, Linkoping, Sweden

[19] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands

[20] Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands

[21] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands

[22] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands

[23] Univ Hosp Heidelberg, Dept Surg, Heidelberg, Germany

[24] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[25] St Orsola Malpighi Hosp, Dept Radiol, IRCCS Azienda Osped Univ Bologna, Bologna, Italy

[26] Univ Hosp Oslo, Dept Radiol, Oslo, Norway

[27] Aintree Univ Hosp NHS Fdn Trust, Dept Surg, Liverpool, Merseyside, England

[28] Univ Hosp Heidelberg, Dept Radiol, Heidelberg, Germany

[29] Western Hlth Footscray, Dept Surg, Footscray, Vic, Australia

[30] Univ Hosp Dr Josep Trueta Girona, Dept Radiol, Girona, Spain

[31] Royal Prince Alfred Hosp, Dept Surg, Camperdown, NSW, Australia

[32] Monash Hlth, Dept Surg, Clayton, Vic, Australia

[33] Univ Hosp Germans Trias I Pujol, Dept Surg, Badalona, Spain

[34] Aintree Univ Hosp NHS Fdn Trust, Dept Radiol, Liverpool, Merseyside, England

[35] Monash Hlth, Dept Radiol, Clayton, Vic, Australia

[36] Osped San Raffaele, Dept Radiol, Milan, Italy

[37] CHU UCLouvain Namur, Dept Radiol, Namur, Belgium

[38] Amsterdam Univ Med Ctr Locat AMC, Dept Radiol, Amsterdam, Netherlands

[39] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden

[40] CHU Liege, Dept Surg, Liege, Belgium

[41] Amsterdam Univ Med Ctr Locat AMC, Dept Surg, Amsterdam, Netherlands

[42] Hosp Clin Barcelona, Dept Surg, Barcelona, Spain

[43] Univ Hosp Oslo, Dept Surg, Oslo, Norway

[44] Hosp Parc Tauli Sabadell, Dept Surg, Sabadell, Spain

[45] Hosp Parc Tauli Sabadell, Dept Radiol, Sabadell, Spain

[46] Univ Hosp Mutua Terassa, Dept Radiol, Terassa, Spain

[47] CHU Liege, Dept Radiol, Liege, Belgium

[48] Gemelli Univ Hosp Rome, Dept Surg, Rome, Italy

[49] Amphia, Dept Surg, Breda, Netherlands

[50] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain

来源：

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 2022年 / 45卷 / 09期

关键词：

Colorectal cancer liver metastases (CRLM); Portal vein embolization (PVE); Hepatic vein embolization (HVE); Combined portal- and hepatic vein embolization (PVE; HVE); Liver hypertrophy; Future liver remnant (FLR); HEPATOBILIARY SCINTIGRAPHY; 2-STAGE HEPATECTOMY; VENOUS DEPRIVATION; COMPLETE RESECTION; MAJOR HEPATECTOMY; MULTIPLE;

D O I：

10.1007/s00270-022-03176-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Study Purpose The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases. Methods The DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection. Results Not applicable. Conclusion DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR.

引用

页码：1391 / 1398

页数：8

共 25 条

[21] Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients
Shindoh, Junichi
Tzeng, Ching-Wei D.
Aloia, Thomas A.
Curley, Steven A.
Huang, Steven Y.
Mahvash, Armeen
Gupta, Sanjay
Wallace, Michael J.
Vauthey, Jean-Nicolas
[J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (01) : 45 - 51
[22] Two-stage strategy for patients with extensive bilateral colorectal liver metastases
Tsai, Susan
Marques, Hugo P.
de Jong, Mechteld C.
Mira, Paulo
Ribeiro, Vasco
Choti, Michael A.
Schulick, Richard D.
Barroso, Eduardo
Pawlik, Timothy M.
[J]. HPB, 2010, 12 (04) : 262 - 269
[23] Controversies in the Use of Portal Vein Embolization
van Gulik, Thomas M.
van den Esschert, Jacomina W.
de Graaf, Wilmar
van Lienden, Krijn P.
Busch, Olivier R. C.
Heger, Michal
van Delden, Otto M.
Lameris, Johan S.
Gouma, Dirk J.
[J]. DIGESTIVE SURGERY, 2008, 25 (06) : 436 - 444
[24] Portal Vein Embolization Before Liver Resection: A Systematic Review
van Lienden, K. P.
van den Esschert, J. W.
de Graaf, W.
Bipat, S.
Lameris, J. S.
van Gulik, T. M.
van Delden, O. M.
[J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (01) : 25 - 34
[25] Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
Wicherts, Dennis A.
Miller, Rafael
de Haas, Robbert J.
Bitsakou, Georgia
Vibert, Eric
Veilhan, Luc-Antoine
Azoulay, Daniel
Bismuth, Henri
Castaing, Denis
Adam, Rene
[J]. ANNALS OF SURGERY, 2008, 248 (06) : 994 - 1005

← 1 2 3 →